# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Nov 25, 2025

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2025-11-25
- Accepted by EDGAR: Nov 25, 2025, 16:10 ET
- Period: 2025-11-25
- Accession: 0000879407-25-000027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000087940725000027/arwr-20251125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000087940725000027/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000087940725000027/arwr-20251125.htm

Filed Nov 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000879407-25-000027. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.